PAULA HASENAUER: Open Payments
NPI 1346632452 · SWEDESBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 10 payments from 6 companies in 2025. Trend: 2023 $458 · 2024 $170 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $153 |
| Lundbeck LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, COBENFY.
Industry payments across NJ — which companies pay providers there.
